Today’s pharma news reflects in a rapid momentum with new oncology expansion, drug innovation and disease control initiatives
Alembic Pharmaceuticals has secured USFDA approval for its generic prucalopride tablets, drawing sharp market attention
India’s healthcare sector is set for a major technology push as the Tata Elxsi-SCTIMST Partnership brings together engineering expertise and medical research capabilities.
The Centre's healthcare compliance overhaul could become a major boost for hospitals in smaller cities. The government plans to simplify regulations and reduce the burden of multiple inspections. The healthcare compliance reforms aim to improve...
Hyderabad strengthens its healthcare landscape with a dedicated centre focused on diabetic wound care, advanced wound healing, and limb salvage
Aster DM has announced INR a 1,315 crore investment to strengthen Karnataka healthcare through new hospitals and expanded medical facilities.
The global and Indian pharmaceutical landscape continues to evolve rapidly, driven by drug trials, financial growth and healthcare expansion
Relopduo has officially entered the Indian market. The launch marks another step in strengthening cancer treatment options.
MedTech Innovation is accelerating in India as Tata Elxsi partners with Sree Chitra Tirunal Institute for Medical Sciences and Technology
Onco-derma therapy is transforming cancer care in India with the launch of Relopduo, a fixed-dose combination of nivolumab and relatlimab by Bristol Myers Squibb
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")